Crossref
journal-article
Elsevier BV
Cancer Cell (78)
References
35
Referenced
294
{'key': '10.1016/S1535-6108(03)00276-9_BIB1', 'series-title': 'Made to Measure', 'author': 'Ball', 'year': '1997'}
/ Made to Measure by Ball (1997)10.1016/S0140-6736(95)90755-6
/ Lancet / Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas by Brem (1995){'key': '10.1016/S1535-6108(03)00276-9_BIB3', 'first-page': '2', 'article-title': 'Polymer-based drug delivery to the brain', 'volume': '3', 'author': 'Brem', 'year': '1996', 'journal-title': 'Sci. Med.'}
/ Sci. Med. / Polymer-based drug delivery to the brain by Brem (1996){'key': '10.1016/S1535-6108(03)00276-9_BIB4', 'first-page': '1878', 'article-title': 'Antiangiogenic scheduling of chemotherapy improves efficacy against experimental drug-resistant cancer', 'volume': '60', 'author': 'Browder', 'year': '2000', 'journal-title': 'Cancer Res.'}
/ Cancer Res. / Antiangiogenic scheduling of chemotherapy improves efficacy against experimental drug-resistant cancer by Browder (2000){'key': '10.1016/S1535-6108(03)00276-9_BIB5', 'first-page': '6831', 'article-title': 'Cationic charge determines the distribution of liposomes between the vascular and extravascular compartments of tumors', 'volume': '62', 'author': 'Campbell', 'year': '2002', 'journal-title': 'Cancer Res.'}
/ Cancer Res. / Cationic charge determines the distribution of liposomes between the vascular and extravascular compartments of tumors by Campbell (2002)10.1016/0960-0760(90)90446-R
/ J Steroid Biochem. Mol. Biol. / A new extra long acting depot preparation of the LHRH analogue Zoladex®. First endocrinological and pharmacokinetic data in patients with advanced prostate cancer by Dijkmana (1990)10.1038/nrd1088
/ Nat. Rev. Drug Discov. / The dawning era of polymer therapeutics by Duncan (2003)10.1097/00006123-199811000-00093
/ Neurosurgery / Local delivery of chemotherapy prolongs survival in experimental brain metastases from breast cancer by Ewend (1998)10.1074/jbc.M306176200
/ J. Biol. Chem. / Structural and functional uncoupling of the enzymatic and angiogenic inhibitory activities of TIMP-2 by Fernandez (2003)10.1056/NEJM199511023331807
/ N. Engl. J. Med. / Drug therapy–Nicotine medications for smoking cessation by Henningfield (1995)10.1146/annurev.bioeng.1.1.241
/ Annu. Rev. Biomed. Eng. / Transport of molecules, particles, and cells in solid tumors by Jain (1999)10.1038/nm0901-987
/ Nat. Med. / Normalizing the tumor vasculature with anti-angiogenic therapy by Jain (2001){'key': '10.1016/S1535-6108(03)00276-9_BIB13', 'first-page': '7669', 'article-title': 'Continuous administration of endostatin by intraperitoneally implanted osmotic pump improves the efficacy and potency of therapy in a mouse xenograft tumor model', 'volume': '61', 'author': 'Kisker', 'year': '2001', 'journal-title': 'Cancer Res.'}
/ Cancer Res. / Continuous administration of endostatin by intraperitoneally implanted osmotic pump improves the efficacy and potency of therapy in a mouse xenograft tumor model by Kisker (2001)10.1172/JCI8829
/ J. Clin. Invest. / Continuous low-dose therapy with vinblastine and VEGF receptor-2 antibody induces sustained tumor regression without overt toxicity by Klement (2000){'issue': 'Suppl', 'key': '10.1016/S1535-6108(03)00276-9_BIB15', 'first-page': '5', 'article-title': 'Drug delivery and targeting', 'volume': '392', 'author': 'Langer', 'year': '1998', 'journal-title': 'Nature'}
/ Nature / Drug delivery and targeting by Langer (1998)10.1038/263797a0
/ Nature / Polymers for the sustained release of proteins and other macromolecules by Langer (1976)10.1126/science.935859
/ Science / Isolation of a cartilage factor that inhibits tumor neovascularization by Langer (1976)10.1227/01.NEU.0000073783.96617.3A
/ Neurosurgery / Gliadel for pituitary adenomas and craniopharyngiomas by Laws (2003){'key': '10.1016/S1535-6108(03)00276-9_BIB19', 'first-page': '2731', 'article-title': 'Antitumor effects in mice of low-dose (metronomic) cyclophosphamide administered continuously through the drinking water', 'volume': '62', 'author': 'Man', 'year': '2002', 'journal-title': 'Cancer Res.'}
/ Cancer Res. / Antitumor effects in mice of low-dose (metronomic) cyclophosphamide administered continuously through the drinking water by Man (2002)-
McCarthy, S. (2003). Antiangiogenesis drug promising for metastatic colorectal cancer - New treatments for colorectal cancer might improve patients' survival, investigators reported at ASCO. Lancet 361, 1959.
(
10.1016/S0140-6736(03)13603-3
) 10.1038/nbt0791-630
/ Biotechnology / Inhibitors of angiogenesis by Moses (1991)10.1073/pnas.96.6.2645
/ Proc. Natl. Acad. Sci. USA / Troponin I is present in human cartilage and inhibits angiogenesis by Moses (1999)10.1248/cpb.36.1095
/ Chem. Pharm. Bull. / A new technique to efficiently entrap leuprolide acetate into microcapsules of polylactic acid and copoly(lactic/glycolic acid) by Ogawa (1988)10.1016/S0169-409X(97)00050-1
/ Adv. Drug Deliv. Rev. / One- and three-month release injectable microspheres of the LH-RH superagonist leuprorelin acetate by Okada (1997)10.1002/jps.2600711214
/ J. Pharm. Sci. / Vaginal absorption of a potent luteinizing-hormone-releasing hormone analog (leuprolide) in rats-1-absorption by various routes and absorption enhancement by Okada (1982)10.1016/0092-8674(94)90200-3
/ Cell / Angiostatin by O'Reilly (1994)10.1016/S0092-8674(00)81848-6
/ Cell / Endostatin by O'Reilly (1997)10.1126/science.8134835
/ Science / New challenges in biomaterials by Peppas (1994)- Prausnitz, M., Mitragotri, S., and Langer, R. (2003). Current status and future potential of transdermal drug delivery. Nature Drug Discovery, in press.
{'key': '10.1016/S1535-6108(03)00276-9_BIB30', 'first-page': '709', 'article-title': 'Multi-pulse drug delivery from a resorbable polymeric microchip device', 'volume': '2', 'author': 'Richards-Grayson', 'year': '2003', 'journal-title': 'Nat. Mater.'}
/ Nat. Mater. / Multi-pulse drug delivery from a resorbable polymeric microchip device by Richards-Grayson (2003)10.1038/16898
/ Nature / A controlled-release microchip by Santini (1999)10.1016/S0090-4295(03)00330-3
/ Urology / An eight-month clinical study of LA-2575 30.0 mg by Sartor (2003)10.1097/00006123-199707000-00011
/ Neurosurgery / Interstitial chemotherapy with carmustine-loaded polymers for high-grade gliomas by Valtonen (1997)10.3171/jns.1995.82.4.0635
/ J. Neurosurg. / The role of minocycline in the treatment of intracranial 9L glioma by Weingarten (1995)10.1093/neuonc/5.2.79
/ Neuro-oncol. / A phase 3 trial of local chemotherapy with biodegradable carmustine (BCNU) wafers (Gliadel wafers) in patients with primary malignant gliomas by Westphal (2003)
Dates
Type | When |
---|---|
Created | 21 years, 4 months ago (April 14, 2004, 5:27 a.m.) |
Deposited | 6 years, 6 months ago (Feb. 13, 2019, 9:54 p.m.) |
Indexed | 3 days, 11 hours ago (Sept. 3, 2025, 6:31 a.m.) |
Issued | 21 years, 10 months ago (Nov. 1, 2003) |
Published | 21 years, 10 months ago (Nov. 1, 2003) |
Published Print | 21 years, 10 months ago (Nov. 1, 2003) |
@article{Moses_2003, title={Advancing the field of drug delivery}, volume={4}, ISSN={1535-6108}, url={http://dx.doi.org/10.1016/s1535-6108(03)00276-9}, DOI={10.1016/s1535-6108(03)00276-9}, number={5}, journal={Cancer Cell}, publisher={Elsevier BV}, author={Moses, Marsha A and Brem, Henry and Langer, Robert}, year={2003}, month=nov, pages={337–341} }